LC-Plasma-based Vaccine Research Selected for SCARDA Project

– Towards the Development of a Vaccine to prevent Respiratory Virus Infection – TOKYO–(BUSINESS WIRE)–May. 08, 2024 Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization against infectious diseases. We now announce that a […]

A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer

MONTREAL–(BUSINESS WIRE)–Apr. 17, 2024 Medisca, a global company specializing in personalized pharmaceutical solutions, is pleased to announce the appointment of Sanjay D. Goorachurn as the company’s new CEO, as founders, Tony Dos Santos and Maria Zaccardo, transition into strategic advisory roles as Chair and Vice Chair, respectively. Coinciding with the company’s 35th anniversary, this decision […]

Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Accelerate Clinical Trials Innovation

Agreement spans wide range of Medidata’s solutions to enhance clinical trial efficiency NEW YORK–(BUSINESS WIRE)–Mar. 22, 2024 Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced it has renewed its relationship with the PPD clinical research business of Thermo Fisher Scientific Inc. The agreement features […]

Mitsubishi Corporation Life Sciences Published New Study regarding the Effect of Ingestion of Cysteine Peptide containing Glutathione on Skin Brightness

TOKYO–(BUSINESS WIRE)–Mar. 12, 2024 Mitsubishi Corporation Life Sciences Limited (Head Office: Chiyoda-ku, Tokyo Japan; Koji Kishimoto, representative director and president) conducted the clinical study regarding skin brightness in cysteine peptide and published it in Cosmetics 2023, 10, 72. In this study, Mitsubishi Corporation Life Sciences defined glutathione (GSH), cysteinylglycine (Cys-Gly), and glutamylcysteine (-Glu-Cys) as cysteine […]

Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency

Collaboration will harness Medidata Electronic Clinical Outcome Assessment (eCOA) for remote patient engagement and real-time data capture NEW YORK–(BUSINESS WIRE)–Feb. 06, 2024 Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, and Sanofi Vaccines, today announced a collaboration to harness Medidata eCOA to deploy in vaccine studies. […]

Timeline a Swiss Longevity Biotech Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders including L’Oréal and Nestlé

LAUSANNE, Switzerland–(BUSINESS WIRE)–Jan. 17, 2024 Timeline, a consumer health biotech company at the forefront of developing innovative solutions for healthy aging and longevity, today announces that it raised CHF 56M (USD 66M) in an oversubscribed Series D financing round. This marks a significant milestone for the company and includes strategic investments from two global industry […]

Xenco Medical Unveils the TrabeculeX Continuum a Breakthrough Convergence of Digital Health and Biomaterials at CES 2024 in Las Vegas the World’s Largest Technology Conference

SAN DIEGO–(BUSINESS WIRE)–Jan. 16, 2024 On January 11th, trailblazing medical technology company Xenco Medical unveiled its convergent technology bridging Digital Health and Biomaterials by showcasing its TrabeculeX Continuum™ at the 2024 Consumer Electronics Show in Las Vegas, Nevada. Comprising the FDA-cleared TrabeculeX Bioactive Matrix™ and the TrabeculeX Recovery App™, the TrabeculeX Continuum is the first […]

Kirin iMUSE Immune Care and Healthya Visceral Fat Down will go on sale on Tuesday November 28!

A special dual-care functional food product from iMUSE, our immune care brand, and Healthya, a visceral fat care brand TOKYO–(BUSINESS WIRE)–Nov. 27, 2023 Kirin Holdings Company, Limited (TOKYO:2503) will launch a dual-care functional food supplement Kirin iMUSE Immuno-Care and Healthya Visceral Fat Down on November 28 (Tuesday). This product is a collaboration between Kirin iMUSE, […]

Japan’s First Discovery*1 on Visceral Fat and Immune Activity in Joint Research by Kirin Holdings and Kao

TOKYO–(BUSINESS WIRE)–Nov. 27, 2023 Kirin Holdings Company, Limited (TOKYO:2503) and Kao Corporation (TOKYO:4452) will participate in the Wakayama Health Promotion Study, a cohort study*2 led by Wakayama Medical University and organized by the Health Promotion Research Center (HPRC), a non-profit organization. Kao and Kirin Holdings conducted a joint study from November 2022 to investigate the […]

AstraZeneca launches Evinova a health-tech business to accelerate innovation across the life sciences sector the delivery of clinical trials and better health outcomes

Evinova will operate as a separate health-tech business within AstraZeneca Evinova’s globally-scaled digital health solutions are evidence-led, science-based and human experience-driven to serve clinical trial sponsors, clinical research organisations (CROs), clinical trial site care teams and patients First strategic collaborations with globally-leading CROs Parexel and Fortrea enable Evinova’s digital health solutions to be offered to […]

SMK Entered into Capital and Business Alliance Agreement with Canary Speech (US)

Acquired Exclusive Commercialization and Distribution Rights for Speech-based Analytic Technology for Diseases such as Dementia in Japanese and Asian Market TOKYO–(BUSINESS WIRE)–Nov. 16, 2023 SMK Corporation (TOKYO: 6798) ( (President, CEO and COO: Yasumitsu Ikeda, hereinafter referred to as SMK) announced that it has entered into a capital and business alliance agreement with Canary Speech, […]

Ketamine Clinic in Japan for Inbound Medical Treatment: Nagoya Anesthesia Clinic

NAGOYA, Japan–(BUSINESS WIRE)–Nov. 14, 2023 Nagoya Anesthesia Clinic (, located in Nagoya City, Aichi Prefecture, Japan, has initiated inbound medical treatment for treatment-resistant depression, other mental disorders, and intractable chronic pain, utilizing the groundbreaking drug Ketamine. Over the past 15 years, the clinic has provided ketamine therapy through more than 1300 ketamine infusions. Our distinctive […]